• FOLLOW US
Video Player
  • Email
  • share

Cautionary tale for Japan M&A in Ranbaxy fail

Daiichi Sankyo is giving up control of Ranbaxy Laboratories to Sun Pharma for $3.2 billion. Breakingviews' Peter Thal Larsen says it serves as a reminder of what can go wrong in overseas ventures.

http://www.digtriad.com/video/3439725532001/49924258001/Cautionary-tale-for-Japan-MampA-in-Ranbaxy-fail http://cdn.newslook.com/df/df1df1ddf74b87977e3026df0ad3107b/images/frame_ext.jpg Cautionary tale for Japan M&A in Ranbaxy fail Daiichi Sankyo is giving up control of Ranbaxy Laboratories to Sun Pharma for $3.2 billion. Breakingviews' Peter Thal Larsen says it serves as a reminder of what can go wrong in overseas ventures. SUNZPeter Thal LarsenFinanceSun Pharmaceuticals Industries LtdTARA JOSEPHReutersnewslookUnited States of AmericaindiaWorldJapan 02:08

Next Up

    

More Videos

National and World News - Recent

Page 1 of 13